ZLD 2.86% 72.0¢ zelira therapeutics limited

Ann: Zelira Phase 1 Chronic Pain Trial Meets Clinical Endpoints, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 776 Posts.
    lightbulb Created with Sketch. 65
    This is a phase I trial. Reports on efficacy means shit here. It’s all about pharmacokinetics and the safety profile of their formulation

    no strong evidence on efficacy reported for 7 patients? No shit!!
 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.